T1	HMM 396 424	overall survival probability
T2	HMM 579 589	recurrence
T3	HMM 669 690	multivariate analysis
T4	HMM 814 831	nodal involvement
T5	HMM 872 888	age distribution
T6	HMM 917 941	sizofiran administration
T7	HMM 974 993	primary tumour size
